Article ID Journal Published Year Pages File Type
4301055 Journal of Surgical Research 2013 7 Pages PDF
Abstract

BackgroundThe purpose of the present study was to clarify the prognostic significance of human leukocyte antigen (HLA) class I expression in patients with non–small-cell lung cancer who underwent complete surgical resection.Patients and methodsThe expression of HLA class I molecules was evaluated in 403 resected NSCLC specimens using immunohistochemistry. The results were scored as the percentage of stained tumor cells and were categorized into three groups: 0%–24% (decreased), 25%–79% (heterogeneous), and 80% or more (normal).ResultsThe expression of HLA class I was evaluated in 124 tumors in the normal expression group, 181 tumors in the heterogeneous expression group, and 98 tumors in the decreased expression group. The 5-year survival rate of all patients after surgery according to the HLA class I expression in the normal, heterogeneous, and decreased groups was 76.6%, 65.9%, and 76.1%, respectively. The prognosis was significantly better in the normal expression group than in the heterogeneous group. Normal HLA class I expression also correlated with favorable survival in patients with stage I disease.ConclusionsThe normal expression of HLA class I was associated with a favorable prognosis compared with the heterogeneous expression group, but no significant difference was observed between the normal expression and decreased expression groups.

Related Topics
Health Sciences Medicine and Dentistry Surgery
Authors
, , , , , , , , , , , ,